Clinical Trials for: gadoteridol
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Status: Completed Condition: Brain Metastases
Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
Status: Completed Condition: Diagnostic Imaging; Central Nervous System Diseases
Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain
Status: Completed Condition: Brain Disease
Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)
Status: Completed Condition: Coronary Artery Disease; Type 1 Diabetes Mellitus
Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease
Status: Active, not recruiting Condition: Renal Insufficiency
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|INJECTABLE;INJECTION||020131||Nov 16, 1992||RX||Yes||5,846,519||<disabled>|
|INJECTABLE;INJECTION||021489||Oct 9, 2003||RX||Yes||5,846,519||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639